Alt
/content/dam/asset-migration/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Dr Chris Harper.jpg

Dr Chris Harper

Dr Chris Harper
MBBS, DIP OBSTETS, DRACOG, FRANZCR, Radiation Oncologist

Languages spoken

English

Overview

Centres

Wembley (Oncology)
Wembley (Oncology)
-31.94160066819861, 115.82249058453726
/au/our-centres/wembley
Murdoch (Oncology)
Murdoch (Oncology)
-32.067130818740424, 115.84572533810733
/au/our-centres/murdoch-oncology

Treatments

Benign treatments
Service
Service/Benign
Service/Benign/Benign
Service/Benign/Benign/Radiation Therapy For Benign Conditions
Image-guided radiation therapy (IGRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Image Guided Radiation Therapy
Intensity-modulated radiation therapy (IMRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Intensity Modulated Radiation Therapy
Stereotactic ablative/body radiation therapy (SABR/SBRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Stereotactic Ablative Radiation Therapy

Specialises in

Benign
Service
Service/Benign
Brain & spine cancer
Condition
Condition/Cancer
Condition/Cancer/Brain and Spine Cancer
Gastrointestinal cancer
Condition
Condition/Cancer
Condition/Cancer/Gastrointestinal Cancer
Genitourinary cancer
Condition
Condition/Cancer
Condition/Cancer/Genitourinary Cancer
Lung cancer
Condition
Condition/Cancer
Condition/Cancer/Lung Cancer
Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate Cancer
Skin cancer
Condition
Condition/Cancer
Condition/Cancer/Skin Cancer

Special clinical interests in benign, urological, gastrointestinal, skin, neurological and Stereotactic Radiosurgery

Chris completed his initial medical and radiation oncology training in Western Australia before undertaking post-graduate studies at Middlesex Hospital (UK), Princess Margaret Hospital (Toronto, Canada), and the Shands Cancer Centre (University of Florida, Gainesville, USA). He is the medical director at GenesisCare Wembley, holds a clinical staff position at Sir Charles Gairdner Hospital, and is accredited as a visiting consultant at a number of private hospitals.

Chris has specialised expertise in advanced radiotherapy techniques including stereotactic radiosurgery, stereotactic body radiation therapy, episcleral plaque brachytherapy for choroidal melanoma, and image guided radiation therapy, including IMRT. He has also completed training on the use of the CyberKnife® Robotic Radiosurgery System. As an expert in his field, Chris has been involved with many notable committees. For 10 years until 2017, he was on the Medical Advisory Committee at St John of God Subiaco Hospital. 

He was also chairman of the Radiation Oncology Economics Committee and the Australian Association of Private Radiation Oncology Practices. He is a past board member of the Faculty of Radiation Oncology of the Royal Australian and New Zealand College of Radiologists (RANZCR). He has also been a guest editor for the International Journal of Stereotactic Radiosurgery. Chris has published over ten papers and is involved in ongoing research projects relating to predominantly prostate, intracranial, lung and spinal tumours. 

Clinical interests

  • Chris’ key clinical interests are in neuro-oncology (brain, skull base and ocular tumours), skin, lower gastrointestinal tumours, head and neck cancers, urological cancers and neurological and Stereotactic Radiosurgery. 
  • His current major technical interests are in the field of stereotactic ablative radiation therapy (SABR).

Professional memberships

  • American Society for Therapeutic Radiation and Oncology (ASTRO)
  • International Stereotactic Radiosurgery Society (ISRS)
  • Trans Tasman Radiation Oncology Group (TROG)